DePuy Orthopaedics, a unit of Johnson & Johnson, has received supplemental premarket approval from the FDA for a 36-millimeter version of its Ceramax Ceramic Total Hip System. The implantable device was first approved in 2010 for noncemented use in adult patients receiving total hip replacements.
J&J unit gets supplemental FDA OK for hip replacement device
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||